We've merged with Palleos Healthcare to form a wide-reaching European CRO.
Find out more
Clinical Research Associates or CRAs play a crucial role in the successful execution of studies and are engaged in numerous activities. By embracing relevant clinical trial site management strategies, CRAs ensure all site processes are in line with the protocol, contribute to faster study timelines and substantial cost savings for sponsors.
At OCT Clinical, CRAs are responsible for conducting training to investigational center staff, including training on protocol implementation, data collection and data transferring, as well as adverse event reporting. With effective software, CRAs set up workflows that show sites which tasks and documents to complete, and leave questions or comments on documents. They check site files to ensure that all essential documents are filed and well up to date, which helps to keep data integrity and guarantee compliance with ethical standards and regulatory requirements. Such a meticulous approach allows us to identify potential issues and protocol deviations.
CRAs foster strong relationships with sites, working closely with various clinical staff and promoting a collaborative and supportive environment. In addition, they act as intermediaries between sponsors and investigators, facilitating clear and efficient communication. Clinical Research Associates perform regular center visits to assess performance and data quality. All this contributes to early risk mitigation and timely implementation of appropriate corrective actions. Their active involvement in on-site and remote site monitoring can provide invaluable clinical insights and ensure adherence to regulatory guidelines and study protocols.
To sum up, by streamlining processes and ensuring compliance, CRAs contribute to faster study completion. Through efficient site management, they minimize delays in patient recruitment, data collection, and overall trial execution. If you want to learn more about efficient clinical trial site management services or other CRO services, please reach out to the OCT team.
OCT Clinical is now operating under Palleos Healthcare brand name.
“The merger will undoubtedly create significant synergies, not just doubling but squaring the expertise of both companies”, Philip Räth, Ph.D., managing director at Palleos, said in the release.
“OCT Clinical is proud to join forces with palleos healthcare, as it has an excellent reputation in the industry it serves. Now we can offer tailored solutions to our clients to meet their diverse clinical research needs and accelerate the time of bringing their products to market”, Dmitry Sharov, CEO at OCT Clinical.
